In addition, YTHDF2 was found to be upregulated in lung cancer tissues, to promote cell growth in lung cancer, and to bind directly to the m6A-modified site in the 6-phosphogluconate dehydrogenase (6PGD) 3′ UTR. Here, YTHDF2 is linked to lung carcinoma.